EV/EBITDA
-0.77
-0.16-26.23%
Thu, 28 Nov 2024 00:45:49 GMT
Summary:
Leap Therapeutics EV/EBITDA is currently -0.77, with a fall of -0.16 (-26.23%) during the most recent trading day. Over the past year, it has dropped by -1.00 (-434.78%). LPTX EV/EBITDA is now -201.32% below its all-time high of 0.76.LPTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -26.2% |
| 1 m1 month | +36.4% |
| 3 m3 months | -24.2% |
| 6 m6 months | +1.3% |
| ytdytd | -71.1% |
| 1 y1 year | -434.8% |
| 5 y5 years | -133.3% |
LPTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.53 | -45.3% | -1.77 | +56.5% |
| 3 m | 3 months | -0.34 | -126.5% | -1.77 | +56.5% |
| 6 m | 6 months | 0.20 | -485.0% | -1.77 | +56.5% |
| 1 y | 1 year | 0.29 | -365.5% | -1.77 | +56.5% |
| 3 y | 3 years | 0.76 | -201.3% | -4.47 | +82.8% |
| 5 y | 5 years | 0.76 | -201.3% | -8.54 | +91.0% |
| alltime | all time | 0.76 | -201.3% | -8.54 | +91.0% |
Leap Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.77(+71.1%) |
| 2023 | -0.45(-221.6%) |
| 2022 | 0.37(-108.7%) |
| 2021 | -4.24(+39.9%) |
| Date | Value |
|---|---|
| 2020 | -3.03(+304.0%) |
| 2019 | -0.75(+31.6%) |
| 2018 | -0.57(-67.6%) |
| 2017 | -1.76 |
FAQ
- What is Leap Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Leap Therapeutics?
- What is LPTX EV/EBITDA year-to-date change?
- What is Leap Therapeutics EV/EBITDA year-on-year change?
What is Leap Therapeutics EV/EBITDA?
The current EV/EBITDA of LPTX is -0.77
What is the all time high EV/EBITDA for Leap Therapeutics?
Leap Therapeutics all-time high EV/EBITDA is 0.76
What is LPTX EV/EBITDA year-to-date change?
Leap Therapeutics EV/EBITDA has changed by -0.32 (-71.11%) since the beginning of the year
What is Leap Therapeutics EV/EBITDA year-on-year change?
Over the past year, LPTX EV/EBITDA has changed by -1.00 (-434.78%)